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Figure 2: Median errors of the 
individual bootstraps. 
Figure 1: Proportion of patients who 
converted to CDMS over time. 
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Target audience Researchers with interest in multiple sclerosis (MS) or machine learning 
Purpose To create a fully automated machine-learning-based model that uses MRI data to predict the conversion to MS in patients with clinically 
isolated syndrome (CIS). 
Introduction  
CIS is diagnosed after a first neurological attack and can be considered an early stage of MS as ~80% of all CIS patients will have a second relapse 
within 20 years1. The prediction of this second clinical relapse which marks the clinical conversion to MS (i.e., clinically-definite MS, CDMS) is very 
challenging, and many clinical and radiological predictors of CDMS have been identified1. Machine learning techniques such as support vector machines 
(SVMs) have been widely applied to neuroimaging data in order to associate MRI features with binary clinical outcomes. A single-centre study has 
shown that it is possible to predict short-time conversion after 1 and 3 years with an accuracy of ~75 % using a priori defined features from baseline MRI 
measures and clinical characteristics, which were applied to support vector machines (SVMs)2. 
Random forests are another type of machine learning techniques that can easily be applied to regression problems, and consist of an ensemble of 
decision trees for regression where each tree is created from independent bootstraps from the input data.  
The present study shows the feasibility of using random forests with European multi-centre MRI data (obtained at CIS onset) to predict the actual date of 
conversion to CDMS rather than just a binary outcome at a fixed time point. 
Methods  
Data: This is a retrospective, multi-centre study, organised and developed within the Magnetic Resonance 
in Multiple Sclerosis (MAGNIMS) network (www.magnims.eu). Five different European MS centres 
(Barcelona, Spain; Copenhagen, Denmark; London, United Kingdom; Milan, Italy; Siena, Italy) contributed 
to this study providing 419 T1 weighted (T1w) images acquired at onset of CIS, as well as both date of 
CIS onset and date of conversion based on a second clinical relapse. Patients were scanned in each 
centre following their local MRI protocols. The study received approval from the local ethics committees 
and written informed consent was obtained prior to the study. For the present study, only 203 patients 
who converted to CDMS within 3000 days were included. 
Preprocessing: Intensity non-uniformities in the T1w MRI scans were removed using N33, the brain 
regions were extracted using BET4, and finally all scans were registered nonlinearly to the MNI152 space 
using NiftyReg5. All brain voxels were concatenated to a vector for each patient resulting in a matrix of 
size 203x261701 for the whole cohort. 
Random Forest Regression: The patients were subdivided 100 times in semi-random training and testing 
sets such that every set contains half of the patients from each individual centre. For each of the 100 
training/testing sets a random forest was created by using a training set and the associated time-to-
conversion (in days) as input to the TreeBagger function from the Statistics Toolbox in MATLAB 2013a. 
Each forest consists of 100 independent trees with a minimum of 5 observations per tree leaf. We present 
the average results over all 100 training/testing sets. 
Results 
We gathered MRI data from 203 patients with CIS who converted to CDMS within 8.2 years: 42 % of 
patients converted to CDMS in one year, 65 % in two years, and 91 % in 5 years as shown in Figure 1. 
The median relative error for the prediction of the time to conversion is 0.7 (range 0.57-1.16) with respect 
to the individual patients’ conversion times. The median errors of the each bootstrap can be seen in 
Figure 2. A comparison of the actual time to conversion and the predicted values is shown in Figure 3 for 
one example bootstrap. 
Discussion 
The performance of the regression model we construct demonstrates useful predictive power, especially 
for patients who convert between 1 and 5 years, whereas the errors are quite large for long-term 
converters. This error results partially from a non-uniform distribution of conversion times as 88 % of the 
patients convert within the first 1500 days and the remaining time is covered by training samples from only 
up to 24 patients as shown in Figure 1. However, this reflects the real life situation as 30 % of all CIS 
patients (including non-converters) convert within 1 year and 80 % within 20 years1. The regression 
problem is particularly challenging, because all patients are at a very early stage of the disease and show 
similar characteristics in terms of lesion distribution and T1 signal changes6. 
Conclusion 
We have presented a fully automated, purely image-based approach to estimate the time to clinical 
conversion from CIS onset to MS using a heterogeneous MRI data set previously acquired in different 
European centres. Future work will improve the accuracy by making use of additional MRI modalities such 
as T2 and diffusion weighted images as they reflect microstructural changes, which may be relevant for 
clinical conversion to CDMS. 
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Figure 3: Overview of the actual time 
to conversion (blue circles) and the 
predicted values (red crosses) for one 
example bootstrap. 
